{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:40:23Z","timestamp":1791722423985,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-FC02-02ER63421"],"award-info":[{"award-number":["DE-FC02-02ER63421"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-FC02-02ER63421"],"award-info":[{"award-number":["DE-FC02-02ER63421"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-FC02-02ER63421"],"award-info":[{"award-number":["DE-FC02-02ER63421"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["NIH AG 061847 NIH AG 054022"],"award-info":[{"award-number":["NIH AG 061847 NIH AG 054022"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["NIH AG 061847 NIH AG 054022"],"award-info":[{"award-number":["NIH AG 061847 NIH AG 054022"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["NIH AG 061847 NIH AG 054022"],"award-info":[{"award-number":["NIH AG 061847 NIH AG 054022"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation Graduate Research Fellowship Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Struct Mol Biol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41594-020-0435-3","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T12:03:19Z","timestamp":1592222599000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":149,"title":["Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4207-2697","authenticated-orcid":false,"given":"Qin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4487-0230","authenticated-orcid":false,"given":"David R.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-9043","authenticated-orcid":false,"given":"Michael R.","family":"Sawaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-8226","authenticated-orcid":false,"given":"Peng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-5419","authenticated-orcid":false,"given":"David S.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"435_CR1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"435_CR2","doi-asserted-by":"crossref","first-page":"9662","DOI":"10.1073\/pnas.86.24.9662","volume":"86","author":"AN Roberts","year":"1989","unstructured":"Roberts, A. N. et al. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc. Natl Acad. Sci. USA 86, 9662\u20139666 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR3","first-page":"81","volume":"116","author":"P Westermark","year":"2011","unstructured":"Westermark, P. Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups. J. Med. Sci. 116, 81\u201389 (2011).","journal-title":"J. Med. Sci."},{"key":"435_CR4","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark, P. et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl Acad. Sci. USA 84, 3881\u20133885 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR5","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","volume":"85","author":"GJ Cooper","year":"1988","unstructured":"Cooper, G. J. et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl Acad. Sci. USA 85, 7763\u20137766 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJM200008103430607","volume":"343","author":"JW H\u00f6ppener","year":"2000","unstructured":"H\u00f6ppener, J. W., Ahr\u00e9n, B. & Lips, C. J. Islet amyloid and type 2 diabetes mellitus. N. Engl. J. Med. 343, 411\u2013419 (2000).","journal-title":"N. Engl. J. Med."},{"key":"435_CR7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0046-8177(81)80197-9","volume":"12","author":"AL Maloy","year":"1981","unstructured":"Maloy, A. L., Longnecker, D. S. & Greenberg, E. R. The relation of islet amyloid to the clinical type of diabetes. Hum. Pathol. 12, 917\u2013922 (1981).","journal-title":"Hum. Pathol."},{"key":"435_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbadis.2005.02.001","volume":"1740","author":"C Esapa","year":"2005","unstructured":"Esapa, C. et al. Islet amyloid polypeptide gene promoter polymorphisms are not associated with type 2 diabetes or with the severity of islet amyloidosis. Biochim. Biophys. Acta 1740, 74\u201378 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"435_CR9","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","volume":"178","author":"CA Jurgens","year":"2011","unstructured":"Jurgens, C. A. et al. \u03b2-cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am. J. Pathol. 178, 2632\u20132640 (2011).","journal-title":"Am. J. Pathol."},{"key":"435_CR10","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark, P., Engstr\u00f6m, U., Johnson, K. H., Westermark, G. T. & Betsholtz, C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl Acad. Sci. USA 87, 5036\u20135040 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","volume":"251","author":"C Betsholtz","year":"1989","unstructured":"Betsholtz, C. et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 251, 261\u2013264 (1989).","journal-title":"FEBS Lett."},{"key":"435_CR12","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","volume":"93","author":"CB Verchere","year":"1996","unstructured":"Verchere, C. B. et al. Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc. Natl Acad. Sci. USA 93, 3492\u20133496 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR13","first-page":"998","volume":"6","author":"GT Westermark","year":"2000","unstructured":"Westermark, G. T., Gebre-Medhin, S., Steiner, D. F. & Westermark, P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol. Med. Camb. Mass 6, 998\u20131007 (2000).","journal-title":"Mol. Med. Camb. Mass"},{"key":"435_CR14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2001.01244.x","volume":"54","author":"SC Lee","year":"2001","unstructured":"Lee, S. C. et al. The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels. Clin. Endocrinol. (Oxf.) 54, 541\u2013546 (2001).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"435_CR15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.2040-1124.2011.00102.x","volume":"2","author":"S Morita","year":"2011","unstructured":"Morita, S. et al. Progressive deterioration of insulin secretion in Japanese type 2 diabetic patients in comparison with those who carry the S20G mutation of the islet amyloid polypeptide gene: a long-term follow-up study. J. Diabetes Investig. 2, 287\u2013292 (2011).","journal-title":"J. Diabetes Investig."},{"key":"435_CR16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jmb.2011.12.032","volume":"421","author":"P Cao","year":"2012","unstructured":"Cao, P. et al. Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. J. Mol. Biol. 421, 282\u2013295 (2012).","journal-title":"J. Mol. Biol."},{"key":"435_CR17","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0002-9440(10)64848-1","volume":"157","author":"S Sakagashira","year":"2000","unstructured":"Sakagashira, S. et al. S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am. J. Pathol. 157, 2101\u20132109 (2000).","journal-title":"Am. J. Pathol."},{"key":"435_CR18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s00125-016-4045-x","volume":"59","author":"DT Meier","year":"2016","unstructured":"Meier, D. T. et al. The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets. Diabetologia 59, 2166\u20132171 (2016).","journal-title":"Diabetologia"},{"key":"435_CR19","volume":"6","author":"EH Pilkington","year":"2016","unstructured":"Pilkington, E. H. et al. Pancreatic \u03b2-cell membrane fluidity and toxicity induced by human islet amyloid polypeptide species. Sci. Reports 6, 21274 (2016).","journal-title":"Sci. Reports"},{"key":"435_CR20","doi-asserted-by":"crossref","first-page":"e19273","DOI":"10.7554\/eLife.19273","volume":"6","author":"P Krotee","year":"2017","unstructured":"Krotee, P. et al. Atomic structures of fibrillar segments of hIAPP suggest tightly mated \u03b2-sheets are important for cytotoxicity. Elife 6, e19273 (2017).","journal-title":"Elife"},{"key":"435_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","volume":"308","author":"ET Jaikaran","year":"2001","unstructured":"Jaikaran, E. T. et al. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308, 515\u2013525 (2001).","journal-title":"J. Mol. Biol."},{"key":"435_CR22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1006\/jmbi.1999.3286","volume":"294","author":"MR Nilsson","year":"1999","unstructured":"Nilsson, M. R. & Raleigh, D. P. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 294, 1375\u20131385 (1999).","journal-title":"J. Mol. Biol."},{"key":"435_CR23","doi-asserted-by":"crossref","first-page":"256954","DOI":"10.1155\/2008\/256954","volume":"2008","author":"S Gilead","year":"2008","unstructured":"Gilead, S. & Gazit, E. The role of the 14\u201320 domain of the islet amyloid polypeptide in amyloid formation. Exp. Diabetes Res. 2008, 256954 (2008).","journal-title":"Exp. Diabetes Res."},{"key":"435_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1047-8477(02)00630-5","volume":"141","author":"LA Scrocchi","year":"2003","unstructured":"Scrocchi, L. A. et al. Identification of minimal peptide sequences in the (8\u201320) domain of human islet amyloid polypeptide involved in fibrillogenesis. J. Struct. Biol. 141, 218\u2013227 (2003).","journal-title":"J. Struct. Biol."},{"key":"435_CR25","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1021\/bi701427q","volume":"46","author":"S Luca","year":"2007","unstructured":"Luca, S., Yau, W.-M., Leapman, R. & Tycko, R. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 46, 13505\u201313522 (2007).","journal-title":"Biochemistry"},{"key":"435_CR26","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","volume":"287","author":"S Bedrood","year":"2012","unstructured":"Bedrood, S. et al. Fibril structure of human islet amyloid polypeptide. J. Biol. Chem. 287, 5235\u20135241 (2012).","journal-title":"J. Biol. Chem."},{"key":"435_CR27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41594-019-0248-4","volume":"26","author":"Q Cao","year":"2019","unstructured":"Cao, Q., Boyer, D. R., Sawaya, M. R., Ge, P. & Eisenberg, D. S. Cryo-EM structures of four polymorphic TDP-43 amyloid cores. Nat. Struct. Mol. Biol. 26, 619\u2013627 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"435_CR28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","volume":"25","author":"EL Guenther","year":"2018","unstructured":"Guenther, E. L. et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463\u2013471 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"435_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AWP Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. P. et al. Cryo-EM structures of tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"435_CR30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","volume":"561","author":"B Falcon","year":"2018","unstructured":"Falcon, B. et al. Structures of filaments from Pick\u2019s disease reveal a novel tau protein fold. Nature 561, 137\u2013140 (2018).","journal-title":"Nature"},{"key":"435_CR31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420\u2013423 (2019).","journal-title":"Nature"},{"key":"435_CR32","volume":"9","author":"B Li","year":"2018","unstructured":"Li, B. et al. Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).","journal-title":"Nat. Commun."},{"key":"435_CR33","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41594-019-0322-y","volume":"26","author":"DR Boyer","year":"2019","unstructured":"Boyer, D. R. et al. Structures of fibrils formed by \u03b1-synuclein hereditary disease mutant H50Q reveal new polymorphs. Nat. Struct. Mol. Biol. 26, 1044\u20131052 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"435_CR34","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1038\/s41467-018-06761-6","volume":"9","author":"MG Iadanza","year":"2018","unstructured":"Iadanza, M. G. et al. The structure of a \u03b22-microglobulin fibril suggests a molecular basis for its amyloid polymorphism. Nat. Commun. 9, 4517 (2018).","journal-title":"Nat. Commun."},{"key":"435_CR35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cell.2017.08.048","volume":"171","author":"DT Murray","year":"2017","unstructured":"Murray, D. T. et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell 171, 615\u2013627.e16 (2017).","journal-title":"Cell"},{"key":"435_CR36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12683-8","volume":"10","author":"M Kollmer","year":"2019","unstructured":"Kollmer, M. et al. Cryo-EM structure and polymorphism of A\u03b2 amyloid fibrils purified from Alzheimer\u2019s brain tissue. Nat. Commun. 10, 4760 (2019).","journal-title":"Nat. Commun."},{"key":"435_CR37","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/diab.45.9.1279","volume":"45","author":"S Sakagashira","year":"1996","unstructured":"Sakagashira, S. et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 45, 1279\u20131281 (1996).","journal-title":"Diabetes"},{"key":"435_CR38","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1021\/bi901751b","volume":"49","author":"P Cao","year":"2010","unstructured":"Cao, P., Meng, F., Abedini, A. & Raleigh, D. P. The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors. Biochemistry 49, 872\u2013881 (2010).","journal-title":"Biochemistry"},{"key":"435_CR39","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","volume":"2016","author":"R Akter","year":"2016","unstructured":"Akter, R. et al. Islet amyloid polypeptide: structure, function, and pathophysiology. J. Diabetes Res. 2016, 2798269 (2016).","journal-title":"J. Diabetes Res."},{"key":"435_CR40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","volume":"185","author":"ME Oskarsson","year":"2015","unstructured":"Oskarsson, M. E. et al. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Am. J. Pathol. 185, 834\u2013846 (2015).","journal-title":"Am. J. Pathol."},{"key":"435_CR41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson, J. et al. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474\u2013481 (2004).","journal-title":"Diabetes"},{"key":"435_CR42","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.neurobiolaging.2008.08.019","volume":"31","author":"J Miklossy","year":"2010","unstructured":"Miklossy, J. et al. Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol. Aging 31, 1503\u20131515 (2010).","journal-title":"Neurobiol. Aging"},{"key":"435_CR43","doi-asserted-by":"crossref","unstructured":"Peila, R., Rodriguez, B. L., Launer, L. J. & Honolulu-Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51, 1256\u20131262 (2002).","DOI":"10.2337\/diabetes.51.4.1256"},{"key":"435_CR44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mp.2016.230","volume":"22","author":"I Moreno-Gonzalez","year":"2017","unstructured":"Moreno-Gonzalez, I. et al. Molecular interaction between type 2 diabetes and Alzheimer\u2019s disease through cross-seeding of protein misfolding. Mol. Psychiatry 22, 1327\u20131334 (2017).","journal-title":"Mol. Psychiatry"},{"key":"435_CR45","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1074\/jbc.M311300200","volume":"279","author":"B O\u2019Nuallain","year":"2004","unstructured":"O\u2019Nuallain, B., Williams, A. D., Westermark, P. & Wetzel, R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279, 17490\u201317499 (2004).","journal-title":"J. Biol. Chem."},{"key":"435_CR46","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1074\/jbc.M117.806109","volume":"293","author":"P Krotee","year":"2018","unstructured":"Krotee, P. et al. Common fibrillar spines of amyloid-\u03b2 and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors. J. Biol. Chem. 293, 2888\u20132902 (2018).","journal-title":"J. Biol. Chem."},{"key":"435_CR47","doi-asserted-by":"crossref","first-page":"13095","DOI":"10.1002\/anie.201504973","volume":"54","author":"E Andreetto","year":"2015","unstructured":"Andreetto, E. et al. A hot-segment-based approach for the design of cross-amyloid interaction surface mimics as inhibitors of amyloid self-assembly. Angew. Chem. Int. Ed. Engl. 54, 13095\u201313100 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"435_CR48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10154","volume":"475","author":"SA Sievers","year":"2011","unstructured":"Sievers, S. A. et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 475, 96\u2013100 (2011).","journal-title":"Nature"},{"key":"435_CR49","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","volume":"10","author":"PM Seidler","year":"2018","unstructured":"Seidler, P. M. et al. Structure-based inhibitors of tau aggregation. Nat. Chem. 10, 170\u2013176 (2018).","journal-title":"Nat. Chem."},{"key":"435_CR50","doi-asserted-by":"crossref","first-page":"16451","DOI":"10.1074\/jbc.RA119.009688","volume":"294","author":"PM Seidler","year":"2019","unstructured":"Seidler, P. M. et al. Structure-based inhibitors halt prion-like seeding by Alzheimer\u2019s disease- and tauopathy-derived brain tissue samples. J. Biol. Chem. 294, 16451\u201316464 (2019).","journal-title":"J. Biol. Chem."},{"key":"435_CR51","doi-asserted-by":"crossref","first-page":"e46924","DOI":"10.7554\/eLife.46924","volume":"8","author":"SL Griner","year":"2019","unstructured":"Griner, S. L. et al. Structure-based inhibitors of amyloid beta core suggest a common interface with tau. Elife 8, e46924 (2019).","journal-title":"Elife"},{"key":"435_CR52","doi-asserted-by":"crossref","first-page":"e46775","DOI":"10.7554\/eLife.46775","volume":"9","author":"S Sangwan","year":"2020","unstructured":"Sangwan, S. et al. Inhibition of synucleinopathic seeding by rationally designed inhibitors. Elife 9, e46775 (2020).","journal-title":"Elife"},{"key":"435_CR53","doi-asserted-by":"crossref","first-page":"42803","DOI":"10.1074\/jbc.M406108200","volume":"279","author":"DHJ Lopes","year":"2004","unstructured":"Lopes, D. H. J. et al. Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J. Biol. Chem. 279, 42803\u201342810 (2004).","journal-title":"J. Biol. Chem."},{"key":"435_CR54","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1110\/ps.0201602","volume":"11","author":"W Sheng","year":"2002","unstructured":"Sheng, W. & Liao, X. Solution structure of a yeast ubiquitin-like protein Smt3: the role of structurally less defined sequences in protein\u2013protein recognitions. Protein Sci. 11, 1482\u20131491 (2002).","journal-title":"Protein Sci."},{"key":"435_CR55","doi-asserted-by":"publisher","unstructured":"R\u00f6der, C. et al. Amyloid fibril structure of islet amyloid polypeptide by cryo-electron microscopy reveals similarities with amyloid beta. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2020.02.11.944546 (2020).","DOI":"10.1101\/2020.02.11.944546"},{"key":"435_CR56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41594-018-0064-2","volume":"25","author":"EL Guenther","year":"2018","unstructured":"Guenther, E. L. et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463\u2013471 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"435_CR57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","volume":"151","author":"C Suloway","year":"2005","unstructured":"Suloway, C. et al. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 151, 41\u201360 (2005).","journal-title":"J. Struct. Biol."},{"key":"435_CR58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jsb.2015.08.006","volume":"192","author":"T Grant","year":"2015","unstructured":"Grant, T. & Grigorieff, N. Automatic estimation and correction of anisotropic magnification distortion in electron microscopes. J. Struct. Biol. 192, 204\u2013208 (2015).","journal-title":"J. Struct. Biol."},{"key":"435_CR59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"435_CR60","doi-asserted-by":"crossref","first-page":"e06980","DOI":"10.7554\/eLife.06980","volume":"4","author":"T Grant","year":"2015","unstructured":"Grant, T. & Grigorieff, N. Measuring the optimal exposure for single particle cryo-EM using a 2.6 \u00c5 reconstruction of rotavirus VP6. Elife 4, e06980 (2015).","journal-title":"Elife"},{"key":"435_CR61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"435_CR62","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsb.2017.02.003","volume":"198","author":"S He","year":"2017","unstructured":"He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163\u2013176 (2017).","journal-title":"J. Struct. Biol."},{"key":"435_CR63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"435_CR64","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1107\/S2059798318004655","volume":"74","author":"TC Terwilliger","year":"2018","unstructured":"Terwilliger, T. C., Sobolev, O. V., Afonine, P. V. & Adams, P. D. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr. D Struct. Biol. 74, 545\u2013559 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"435_CR65","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"435_CR66","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1110\/ps.036509.108","volume":"17","author":"JJW Wiltzius","year":"2008","unstructured":"Wiltzius, J. J. W. et al. Atomic structure of the cross-beta spine of islet amyloid polypeptide (amylin). Protein Sci. 17, 1467\u20131474 (2008).","journal-title":"Protein Sci."},{"key":"435_CR67","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1107\/S2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531\u2013544 (2018).","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"435_CR68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"435_CR69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/319199a0","volume":"319","author":"D Eisenberg","year":"1986","unstructured":"Eisenberg, D. & McLachlan, A. D. Solvation energy in protein folding and binding. Nature 319, 199\u2013203 (1986).","journal-title":"Nature"},{"key":"435_CR70","first-page":"217","volume":"29A","author":"D Eisenberg","year":"1989","unstructured":"Eisenberg, D., Wesson, M. & Yamashita, M. Interpretation of protein folding and binding with atomic solvation parameters. Chem. Scr. 29A, 217\u2013221 (1989).","journal-title":"Chem. Scr."},{"key":"435_CR71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/jmbi.1994.1366","volume":"239","author":"P Koehl","year":"1994","unstructured":"Koehl, P. & Delarue, M. Application of a self-consistent mean field theory to predict protein side-chains conformation and estimate their conformational entropy. J. Mol. Biol. 239, 249\u2013275 (1994).","journal-title":"J. Mol. Biol."},{"key":"435_CR72","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/acs.jctc.7b00125","volume":"13","author":"RF Alford","year":"2017","unstructured":"Alford, R. F. et al. The Rosetta all-atom energy function for macromolecular modeling and design. J. Chem. Theory Comput. 13, 3031\u20133048 (2017).","journal-title":"J. Chem. Theory Comput."},{"key":"435_CR73","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11183-z","volume":"10","author":"RA Warmack","year":"2019","unstructured":"Warmack, R. A. et al. Structure of amyloid-beta (20-34) with Alzheimer\u2019s-associated isomerization at Asp23 reveals a distinct protofilament interface. Nat. Commun. 10, 3357 (2019).","journal-title":"Nat. Commun."},{"key":"435_CR74","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2013.08.035","volume":"154","author":"J-X Lu","year":"2013","unstructured":"Lu, J.-X. et al. Molecular structure of beta-amyloid fibrils in Alzheimer\u2019s disease brain tissue. Cell 154, 1257\u20131268 (2013).","journal-title":"Cell"},{"key":"435_CR75","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/anie.201408598","volume":"54","author":"AK Schutz","year":"2015","unstructured":"Schutz, A. K. et al. Atomic-resolution three-dimensional structure of amyloid beta fibrils bearing the Osaka mutation. Angew. Chem. Int. Ed. Engl. 54, 331\u2013335 (2015).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"435_CR76","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/jacs.6b05129","volume":"138","author":"MT Colvin","year":"2016","unstructured":"Colvin, M. T. et al. Atomic resolution structure of monomorphic A\u03b242 amyloid fibrils. J. Am. Chem. Soc. 138, 9663\u20139674 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"435_CR77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","volume":"358","author":"L Gremer","year":"2017","unstructured":"Gremer, L. et al. Fibril structure of amyloid-\u03b2(1\u201342) by cryo\u2013electron microscopy. Science 358, 116\u2013119 (2017).","journal-title":"Science"},{"key":"435_CR78","doi-asserted-by":"crossref","first-page":"E4976","DOI":"10.1073\/pnas.1600749113","volume":"113","author":"MA Walti","year":"2016","unstructured":"Walti, M. A. et al. Atomic-resolution structure of a disease-relevant A\u03b2(1\u201342) amyloid fibril. Proc. Natl Acad. Sci. USA 113, E4976\u2013E4984 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR79","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nsmb.2991","volume":"22","author":"Y Xiao","year":"2015","unstructured":"Xiao, Y. et al. A\u03b2(1\u201342) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease. Nat. Struct. Mol. Biol. 22, 499\u2013505 (2015).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"435_CR80","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"T Luhrs","year":"2005","unstructured":"Luhrs, T. et al. 3D structure of Alzheimer\u2019s amyloid-\u03b2(1\u201342) fibrils. Proc. Natl Acad. Sci. USA 102, 17342\u201317347 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR81","doi-asserted-by":"crossref","first-page":"18349","DOI":"10.1073\/pnas.0806270105","volume":"105","author":"AK Paravastu","year":"2008","unstructured":"Paravastu, A. K., Leapman, R. D., Yau, W.-M. & Tycko, R. Molecular structural basis for polymorphism in Alzheimer\u2019s \u03b2-amyloid fibrils. Proc. Natl Acad. Sci. USA 105, 18349\u201318354 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"435_CR82","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.str.2014.10.022","volume":"23","author":"NG Sgourakis","year":"2015","unstructured":"Sgourakis, N. G., Yau, W.-M. & Qiang, W. Modeling an in-register, parallel \u201cIowa\u201d A\u03b2 fibril structure using solid-state NMR data from labeled samples with Rosetta. Structure 23, 216\u2013227 (2015).","journal-title":"Structure"},{"key":"435_CR83","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/nprot.2007.406","volume":"2","author":"AT Brunger","year":"2007","unstructured":"Brunger, A. T. Version 1.2 of the Crystallography and NMR system. Nat. Protoc. 2, 2728\u20132733 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Nature Structural & Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41594-020-0435-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-020-0435-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41594-020-0435-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:26:35Z","timestamp":1684607195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41594-020-0435-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1038\/s41594-020-0435-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.05.25.114967","asserted-by":"object"}]},"ISSN":["1545-9993","1545-9985"],"issn-type":[{"value":"1545-9993","type":"print"},{"value":"1545-9985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S.E. is an advisor and equity shareholder in ADRx, Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}